SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (938)12/3/2004 6:55:48 PM
From: Miljenko Zuanic  Respond to of 3557
 
SUCKERS!

They should turn back money that they have made from options in this period (99-2004). And/or put blame on "UNRESPONSIBLE" investors that pushed price too high, so their options exercise price was not appropriate!

Miljenko

See Section 1 – “Eligible Options and Optionholders; Number of Replacement Options; Expiration Date,” Section 5 – “Acceptance of Options for Exchange and Grant of Replacement Options” and Section 14 – “Extension of Offer; Termination; Amendment.”

If you validly tender options for exchange and cancellation, and such options are accepted and cancelled, pursuant to the Offer, the number of replacement options you will receive will depend on the exercise price per share of the options you tendered, as follows:

• For options with an exercise price per share greater than or equal to $18.00 and less than or equal to $28.00, you will receive replacement options at an exchange ratio of one (1) replacement option for every 1.5 tendered options.

• For options with an exercise price per share greater than or equal to $28.01 and less than or equal to $37.00, you will receive replacement options at an exchange ratio of one (1) replacement option for every two (2) tendered options.

• For options with an exercise price per share greater than or equal to $37.01, you will receive replacement options at an exchange ratio of one (1) replacement option for every three (3) tendered options.